---
title: "Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274213877.md"
description: "Inovio Pharmaceuticals Inc. (INO) shares rose 5.23% to $1.61 on a mixed trading day, outperforming competitors like Johnson & Johnson and Statera Biopharma. The Dow Jones increased by 0.11%, while NASDAQ fell by 0.72%. Inovio's stock remains 45.95% below its 52-week high of $2.98, reached on September 9th. Trading volume was 1.9 million, surpassing the 50-day average of 1.5 million."
datetime: "2026-01-29T22:26:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274213877.md)
  - [en](https://longbridge.com/en/news/274213877.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274213877.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274213877.md) | [繁體中文](https://longbridge.com/zh-HK/news/274213877.md)


# Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Inovio Pharmaceuticals Inc. (INO) rose 5.23% to $1.61 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,071.56 and the NASDAQ Composite Index falling 0.72% to 23,685.12. Inovio Pharmaceuticals Inc. closed 45.95% short of its 52-week high of $2.98, which the company achieved on September 9th. The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.19% to $227.29, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. (PFE) rose 0.93% to $26.10. Trading volume (1.9 M) eclipsed its 50-day average volume of 1.5 M. Data source: Dow Jones Market Data, FactSet. Data compiled January 29, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 01-29-26 1726ET

### Related Stocks

- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [Sarepta Therapeutics, Inc. (SRPT.US)](https://longbridge.com/en/quote/SRPT.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [Inovio Pharmaceuticals (INO) Expected to Announce Earnings on Thursday](https://longbridge.com/en/news/278204493.md)
- [16:47 ETInovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/278776683.md)
- [INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights | INO Stock News](https://longbridge.com/en/news/278934993.md)
- [16:32 ETInovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/278939723.md)
- [INOVIO to Participate in Upcoming Scientific Conferences | INO Stock News](https://longbridge.com/en/news/278388159.md)